37 studies found for:    Open Studies | "Keratosis, Actinic"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment
Condition: Actinic Keratosis
Interventions: Drug: SR-T100 gel;   Drug: Vehicle gel
2 Recruiting Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses
Condition: Actinic Keratosis
Intervention: Drug: Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm
3 Recruiting Effect of Nigella Sativa in the Treatment of Palmer Arsenical Keratosis
Condition: Arsenical Keratosis
Interventions: Dietary Supplement: Vitamin E;   Dietary Supplement: Nigella sativa;   Dietary Supplement: Placebo
4 Not yet recruiting Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses
Condition: Actinic Keratoses
Interventions: Procedure: Topical retinoid and blue-light therapy with photosensitizing agent;   Procedure: Photodynamic Therapy (PDT)
5 Recruiting Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical Keratosis
Condition: Arsenical Keratosis
Interventions: Other: Leaf extract of A. indica;   Drug: Salicylic Acid (6%);   Other: Petroleum jelly
6 Not yet recruiting Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses
Condition: Actinic Keratoses
Interventions: Drug: NDL-PDT;   Drug: c-PDT;   Drug: placebo c-PDT
7 Recruiting Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Device: Eryfotona AK-NMSC® cream;   Other: Sunscreen SPF 50+
8 Recruiting Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients
Condition: Actinic Keratoses
Interventions: Other: photodynamic therapy;   Drug: imiquimod 5% cream
9 Recruiting Efficacy and Safety Phase II Dose-ranging Study of SR-T100 to Treat Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Vehicle gel;   Drug: SR-T100 with 1.0% of SM;   Drug: SR-T100 with 2.3% of SM
10 Recruiting A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Diclofenac Sodium Gel 3%;   Drug: Solaraze® (diclofenac sodium) Gel 3%;   Drug: Vehicle Topical Gel
11 Recruiting Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.
Condition: Actinic Keratosis
Interventions: Drug: Imiquimod Topical Cream 3.75%;   Drug: Zyclara® (imiquimod) Topical Cream 3.75%;   Drug: Vehicle Topical Cream
12 Recruiting Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp
Condition: Actinic Keratosis
Intervention: Drug: Ingenol Mebutate 0.015%
13 Recruiting Dose-finding Trial Exploring Safety, Tolerability and Efficacy of a Topical Resiquimod Gel in Patients With Multiple Actinic Keratosis Lesions
Condition: Actinic Keratosis
Interventions: Drug: Resiquimod;   Drug: Placebo / Vehicle
14 Recruiting A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities
Condition: Actinic Keratosis
Interventions: Drug: Ingenol mebutate gel 0.05 %;   Drug: Ingenol mebutate gel 0.015 %
15 Recruiting Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Ingenol mebutate gel;   Drug: placebo
16 Recruiting Photodynamic Therapy of Actinic Keratoses With Alacare®
Condition: Actinic Keratosis
Intervention:
17 Recruiting Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Imiquimod Cream, 3.75%;   Drug: Zyclara®;   Other: Vehicle of Test Product
18 Recruiting Observational Trial Assessing Long-term Local Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.
Condition: Actinic Keratosis
Intervention:
19 Recruiting Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic Keratosis
Condition: Actinic Keratosis Olsen Grade I/II
Intervention: Drug: AK 3012
20 Recruiting Fractional CO2 Laser Assisted Photodynamic Therapy
Conditions: Actinic Keratosis;   Basal Cell Carcinoma
Interventions: Drug: Conventional photodynamic therapy;   Drug: Fractional CO2 laser assisted PDT

Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results
Indicates status has not been verified in more than two years